Is Endometrial Cancer Risk Reduced by Oral Bisphosphonate Use?
European Institute of Oncology, Milan; and University of Rome Sapienza, Rome, Italy federica.tomao@uniroma1.it.
Federica
F
Tomao
European Institute of Oncology, Milan, Italy.
Nicoletta
N
Colombo
University of Rome Sapienza, Rome, Italy.
Benedetti
B
Panici
D004164:Diphosphonates / Q000627:therapeutic use*; D016889:Endometrial Neoplasms / Q000517:prevention & control*; D005260:Female; D006801:Humans; D017698:Postmenopause; D018570:Risk Assessment / Q000706:statistics & numerical data*
D004164:Diphosphonates